Chemo-Pharma (CPL) | Stock Overview & Key Data
Chemo-Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹128.00 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Chemo-Pharma
CPL
|
4.62B Small-cap | -0.20% | -9.72% | 10.04% | -11.06% | -12.31% | -5.34% | 232.23% | 82.57% | 325.71% | 1,271.09% | 1,271.09% |
|
Ashok Leyland
ASHOKLEY
|
997.97B Large-cap | 11.83% | 2.98% | -8.72% | -5.47% | -14.70% | 29.86% | 85.46% | 161.85% | 208.73% | 1,137.42% | 1,632.39% |
|
Escorts Kubota
ESCORTS
|
364.07B Large-cap | 0.09% | -6.64% | -8.46% | -24.68% | -26.68% | -11.78% | 26.70% | 136.03% | 1,465.42% | 2,391.11% | 4,332.42% |
|
Vst Tillers Tractors
VSTTILLERS
|
44.84B Small-cap | 0.37% | -2.83% | -6.70% | -20.38% | -25.19% | 19.22% | 59.91% | 110.33% | 135.73% | 836.90% | 836.90% |
|
Uniparts India
UNIPARTS
|
22.69B Small-cap | 4.83% | 23.55% | 51.00% | 32.89% | 37.84% | 70.80% | 14.88% | 361.33% | 307.85% | 307.85% | 307.85% |
|
Indef Manufacturing
BAJAJINDEF
|
10.00B Small-cap | 4.76% | -15.00% | 1.38% | -26.81% | -34.34% | -45.26% | -7.98% | -7.98% | -7.98% | -7.98% | -7.98% |
Ownership & Short Interest
Calculate Your Chemo-Pharma Investment Returns
Long-Term Investment Performance Analysis
Chemo-Pharma stock price in Aug 2016 was ₹20.80, A ₹1,000.00 lump sum investment in Chemo-Pharma made 9 years ago would be worth approximately ₹3,389.42 today, representing a outstanding return of 238.94%. This translates to an annualized return (CAGR) of 13.16%.
9 Years 10 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CPL's 52-week high and low?
- In the last 52 weeks, Chemo-Pharma reached a high of ₹87.75 (on December 11, 2025) and a low of ₹52.67 (on March 30, 2026).
- What is the market cap and P/E ratio for CPL?
- Curious about Chemo-Pharma's size and valuation? Its market capitalization stands at 4.62B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.22, and the forward P/E (looking ahead) is N/A.
- Does CPL pay dividends? If so, what's the yield?
- As for dividends, Chemo-Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Chemo-Pharma's main competitors or similar companies to consider before investing?
When looking at Chemo-Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ashok Leyland
ASHOKLEY997.97B Industrials Farm & Heavy Construction Machinery 29.86% 85.46% Escorts Kubota
ESCORTS364.07B Industrials Farm & Heavy Construction Machinery -11.78% 26.70% Vst Tillers Tractors
VSTTILLERS44.84B Industrials Farm & Heavy Construction Machinery 19.22% 59.91% Uniparts India
UNIPARTS22.69B Industrials Farm & Heavy Construction Machinery 70.80% 14.88% Indef Manufacturing
BAJAJINDEF10.00B Industrials Farm & Heavy Construction Machinery -45.26% -7.98% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Chemo-Pharma Laboratories Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Chemo-Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.97%, the Debt to Equity ratio from the most recent quarter is 48.02, and its Gross Profit Margin stands at 24.93%.
- What is the recent revenue and earnings growth for CPL?
- Looking at Chemo-Pharma's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 40.00%, and quarterly earnings saw a YoY growth of 40.80%.
- How much of CPL stock is held by insiders and institutions?
- Wondering who owns Chemo-Pharma stock? Company insiders (like executives and directors) hold about 69.98% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.